Roche Holding AG (WBO:ROGP) Cyclically Adjusted FCF per Share: €18.43 (As of Dec. 2025)


WBO:ROGP Roche Holding AG WBO:ROGP
54 GF Score
Price €372.00
GF Value €288.76
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Roche Holding AG Cyclically Adjusted FCF per Share?

Roche Holding AG WBO:ROGP +4.20% 54 Cyclically Adjusted FCF per Share is €18.43 as of Dec. 2025. GuruFocus rates WBO:ROGP with a GF Score™ of 54/100 and a GF Value™ of €288.76 (Modestly Overvalued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Roche Holding AG's adjusted free cash flow per share data for the fiscal year that ended in Dec. 2025 was €17.447. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €18.43 for the trailing ten years ended in Dec. 2025.

During the past 12 months, Roche Holding AG's average Cyclically Adjusted FCF Growth Rate was 1.40% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 1.60% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 2.60% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 3.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Roche Holding AG was 24.60% per year. The lowest was 1.60% per year. And the median was 5.05% per year.

As of today (2026-07-02), Roche Holding AG's current stock price is € 372.00. Roche Holding AG's Cyclically Adjusted FCF per Share for the fiscal year that ended in Dec. 2025 was €18.43. Roche Holding AG's Cyclically Adjusted Price-to-FCF of today is 20.18.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Roche Holding AG was 25.53. The lowest was 13.26. And the median was 18.91.


Roche Holding AG  (WBO:ROGP) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Roche Holding AG's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=372.00/18.43
=20.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Roche Holding AG was 25.53. The lowest was 13.26. And the median was 18.91.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Roche Holding AG Cyclically Adjusted FCF per Share Related Terms


Roche Holding AG Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Roche Holding AG's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Roche Holding AG Cyclically Adjusted FCF per Share Chart

Roche Holding AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 18.43

Roche Holding AG Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 18.43

WBO:ROGP vs LLY, JNJ, ABBV: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - General subindustry, Roche Holding AG's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Roche Holding AG Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Roche Holding AG's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Roche Holding AG's Cyclically Adjusted Price-to-FCF falls into.


WBO:ROGP
54GF Score
Roche Holding AG WBO:ROGP
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Roche Holding AG Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Roche Holding AG's adjusted Free Cash Flow per Share data for the fiscal year that ended in Dec. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=17.447/107.2000*107.2000
=17.447

Current CPI (Dec. 2025) = 107.2000.

Roche Holding AG Annual Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201612 10.658 99.380 11.497
201712 13.749 100.213 14.708
201812 15.515 100.906 16.483
201912 18.540 101.063 19.666
202012 12.703 100.241 13.585
202112 18.355 101.776 19.333
202212 16.618 104.666 17.020
202312 15.096 106.461 15.201
202412 20.147 107.128 20.161
202512 17.447 107.200 17.447

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €18.43 mean?
Roche Holding AG (WBO:ROGP) has a Cyclically Adjusted FCF per Share of €18.43 as of Dec. 2025. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Roche Holding AG and its competitors.
Is Roche Holding AG's Cyclically Adjusted FCF per Share too high?
Roche Holding AG's current Cyclically Adjusted FCF per Share is €18.43. Overall, Roche Holding AG has a GF Score™ of 54/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Roche Holding AG's Cyclically Adjusted FCF per Share compare to LLY and JNJ?
Roche Holding AG's Cyclically Adjusted FCF per Share of €18.43 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Roche Holding AG and its competitors. Roche Holding AG's current Cyclically Adjusted FCF per Share is €18.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Roche Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Roche Holding AG (WBO:ROGP) is currently considered Modestly Overvalued. The stock's GF Value™ is €288.76, compared to a current price of €372.00 — trading 28.8% above its estimated fair value. The current Cyclically Adjusted FCF per Share is €18.43. Roche Holding AG's overall GF Score™ is 54/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Roche Holding AG (WBO:ROGP), the current Cyclically Adjusted FCF per Share is €18.43 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Roche Holding AG (WBO:ROGP) Overvalued in 2026?

Based on GuruFocus' analysis, Roche Holding AG stock appears to be overvalued. The current stock price of €372.00 is trading 28.8% above its estimated GF Value™ of €288.76. GuruFocus considers Roche Holding AG to be Modestly Overvalued.

Key valuation signals for WBO:ROGP:

  • Cyclically Adjusted FCF per Share: €18.43
  • GF Value™: €288.76 vs. price of €372.00 (28.8% above fair value)
  • GF Score™: 54/100 with 7 warning signs

No single metric tells the full story. See the WBO:ROGP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Roche Holding AG Business Description

Address Grenzacherstrasse 124, Basel, CHE, 4070
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 40% of pharmaceutical sales, and centralized and point-of-care diagnostics for two-thirds of diagnostic-related sales.
54GF Score

Get the complete analysis for WBO:ROGP

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€372.00
Price
€288.76
GF Value